Farther Finance Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.52M Buy
395,297
+130,842
+49% +$3.42M 0.07% 230
2026
Q1
$7.55M Buy
264,455
+43,681
+20% +$1.16M 0.07% 245
2025
Q4
$5.5M Buy
220,774
+80,552
+57% +$2.03M 0.06% 285
2025
Q3
$3.57M Buy
140,222
+4,723
+3% +$117K 0.05% 297
2025
Q2
$3.28M Buy
135,499
+50,209
+59% +$1.17M 0.07% 252
2025
Q1
$2.09M Buy
85,290
+26,095
+44% +$683K 0.05% 290
2024
Q4
$1.57M Sell
59,195
-1,910
-3% -$51.8K 0.06% 260
2024
Q3
$1.77M Buy
61,105
+6,262
+11% +$183K 0.07% 226
2024
Q2
$1.55M Buy
54,843
+12,131
+28% +$334K 0.08% 206
2024
Q1
$1.18M Buy
42,712
+4,829
+13% +$134K 0.07% 226
2023
Q4
$1.09M Buy
37,883
+11,997
+46% +$363K 0.08% 222
2023
Q3
$859K Buy
25,886
+8,206
+46% +$290K 0.13% 136
2023
Q2
$648K Buy
17,680
+2,302
+15% +$89.6K 0.14% 134
2023
Q1
$627K Buy
15,378
+7,421
+93% +$321K 0.18% 107
2022
Q4
$408K Buy
+7,957
New +$381K 0.16% 128

Other funds holding PFE

Farther Finance Advisors's PFE Position: Q2 2026 in Review

Farther Finance Advisors increased its Pfizer (PFE) stake by 49% in Q2 2026, buying an estimated $3.42M and bringing the position to 395,297 shares worth $9.52M. The position accounts for 0.07% of the portfolio, ranked #230.

Farther Finance Advisors first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Farther Finance Advisors held 395,297 shares of Pfizer worth $9.52M as of Q2 2026.
  • Farther Finance Advisors bought 130,842 Pfizer shares in Q2 2026, an estimated $3.42M.
  • Pfizer made up 0.07% of Farther Finance Advisors's portfolio in Q2 2026, its #230 holding.
  • Farther Finance Advisors first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.